Clin2
NCT06662526Possibly a fitNot yet recruiting

Lithium for preventing mood episode relapse

DementiaBipolar Disorder (BD)Depression - Major Depressive DisorderMild Cognitive Impairment (MCI)

Part of Brain & nervous system, Mental health clinical trials.

This trial tests if lithium can help prevent mood episodes from returning in people with bipolar disorder or major depressive disorder. It aims to see if lithium is a safe and effective longer-term treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
250 people
Ages
55 years to 75 years
Study type
Interventional

Who can take part

  • You must be between 55 and 70 years old.
  • You must have a diagnosis of major depressive disorder or bipolar disorder (type I or II).
  • You must be willing to take lithium and attend study visits.
  • You must not have severe kidney, thyroid, or other unstable medical conditions.
  • You must not have active suicidal thoughts with a plan.
  • You must not have dementia or be dependent on alcohol in the past month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07167563Recruiting
Real-world lithium study for bipolar disorder

This study looks at how lithium works in everyday life for people with bipolar disorder. It aims to learn about real-world treatment patterns and outcomes.

Aarhus
NCT07732933Not yet recruiting
Testing a new lithium delivery method for bipolar disorder

This study tests a new way to deliver lithium, a common treatment for bipolar disorder, using tiny gold particles. It aims to see if this method is safe and effective in laboratory models, which may lead to better treatments with fewer side effects.

Roma
NCT06396312Recruiting
Predicting lithium response in difficult depression

This study looks at how to predict which people with hard-to-treat depression will benefit from adding lithium to their antidepressant. If you have treatment-resistant depression and are considering lithium, this trial may help find the best treatment for you.

Munich, Bavaria
NCT07750925Not yet recruiting
How lithium affects the brain in healthy adults

This trial looks at how lithium affects the brain in healthy people, to better understand bipolar disorder. You will not receive lithium as a treatment but as a research tool, and you'll have brain scans.

Newcastle upon Tyne, Tyne & Wear
NCT06776848Recruiting· Phase 1/Phase 2
Lithium for TBR1-related neurodevelopmental disorder

This trial tests whether taking lithium for 2 years can improve symptoms in people with a TBR1 gene change that causes neurodevelopmental challenges. It aims to see if lithium is safe and helpful for this condition.

Dijon
NCT06134349Recruiting
Bipolar Lithium Imaging Scan Study

This study uses MRI scans to look at how lithium affects the brain in people with bipolar disorder. It may help researchers understand why lithium works and how to use it better.

Leiden, South Holland

Hear when a new Dementia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.